SCHEMBL25540469

SCHEMBL25540469

CC1(C)c2ccc3ccccc3c2-c2cccc(-c3ccc(-c4nc(-c5cccc6ccccc56)cc(-c5cccc6ccccc56)n4)c4ccccc34)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
HTR2C P28335 4/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
DNMT1 P26358 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
DHFR P00374 1/20 0.32
HTR2A P28223 1/20 0.32
PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25538383 1.00 MEN1 (0.36) MEN1KMT2AHTR2CALDH1A1MAPT
SCHEMBL25539564 0.94 MEN1 (0.35) MEN1KMT2AHTR2CALDH1A1MAPT
SCHEMBL25540311 0.94 MEN1 (0.35) MEN1KMT2AHTR2CALDH1A1MAPT
SCHEMBL25538379 0.94 MEN1 (0.35) MEN1KMT2AHTR2CALDH1A1MAPT
SCHEMBL25538382 0.93 MEN1 (0.34) MEN1KMT2AHTR2CALDH1A1MAPT
SCHEMBL25540467 0.93 MEN1 (0.34) MEN1KMT2AHTR2CALDH1A1MAPT
SCHEMBL25538384 0.92 PIM1 (0.43) MEN1KMT2AHTR2CS1PR1S1PR3
SCHEMBL25540463 0.92 PIM1 (0.34) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL25537861 0.92 ALDH1A1 (0.39) MEN1KMT2AHTR2CALDH1A1MAPT
SCHEMBL25537078 0.92 ALDH1A1 (0.39) MEN1KMT2AHTR2CALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MEN1 267/4885KMT2A 1094/4885HTR2C 4636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.